GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IDXG
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Thursday for Interpace Diagnostics Group
(Updated on Apr 18, 2024)

Buy or Hold candidate since Apr 15, 2024 PDF

No changes to the price of Interpace Diagnostics Group stock on the last trading day (Thursday, 18th Apr 2024). During the last trading day the stock fluctuated 0% from a day low at $1.47 to a day high of $1.47. The price has been going up and down for this period, and there has been a -3.29% loss for the last 2 weeks.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 50.18% during the next 3 months and, with a 90% probability hold a price between $1.96 and $3.08 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IDXG Signals & Forecast

There are mixed signals in the stock today. The Interpace Diagnostics Group stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $1.47. On a fall, the stock will find some support from the short-term average at $1.44. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, April 17, 2024, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Interpace Diagnostics Group stock

Interpace Diagnostics Group finds support from accumulated volume at $1.45 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 3.65%

Our recommended stop-loss: $1.41 (-4.04%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IDXG) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Interpace Diagnostics Group to open at $1.47, and during the day (based on 14 day Average True Range), to move between $1.34 and $1.60, which gives a possible trading interval of +/-$0.127 (+/-8.61%) up or down from last closing price. If Interpace Diagnostics Group takes out the full calculated possible swing range there will be an estimated 17.23% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.45 (1.36%) than the resistance at $1.50 (2.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Interpace Diagnostics Group stock A Buy?

Interpace Diagnostics Group holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Interpace Diagnostics Group of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$1.47 ( 0%) $1.47

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IDXG

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.47 .
R2 1.47 .
R1 1.47 .
Current price: 1.47
Support S1 1.47 .
S2 1.47 .
S3 1.47 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.66 12.93 %
R2 1.63 10.88 %
R1 1.50 2.04 %
Current price 1.47
Support S1 1.45 -1.36%
S2 1.35 -8.16%
S3 1.20 -18.37%

FAQ

What is the symbol for Interpace Diagnostics Group Stock and on which exchange is it traded?
The symbol for Interpace Diagnostics Group is IDXG and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Interpace Diagnostics Group Stock?
Interpace Diagnostics Group holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Interpace Diagnostics Group Stock?
Interpace Diagnostics Group Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Interpace Diagnostics Group Stock.

What's the current price of Interpace Diagnostics Group Stock?
As of the end of day on the 2024-04-18, the price of an Interpace Diagnostics Group (IDXG) share was $1.47.

What is the 52-week high and low for Interpace Diagnostics Group Stock?
The 52-week high for Interpace Diagnostics Group Stock is $3.54 and the 52-week low is $0.620.

What is the market capitalization of Interpace Diagnostics Group Stock?
As of the 2024-04-18, the market capitalization of Interpace Diagnostics Group is 6.433M.

When is the next earnings date for Interpace Diagnostics Group?
The upcoming earnings date for Interpace Diagnostics Group is May 10, 2024.
Click to get the best stock tips daily for free!

About Interpace Diagnostics Group

Interpace Diagnostics Group Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; PanDNA, a molecular only version of PancraGEN that provides physicians a snapshot of a limited n... IDXG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT